CORRIGENDUM: Low-pass whole-genome sequencing in clinical cytogenetics: a validated approach
- PMID: 28072407
- DOI: 10.1038/gim.2016.187
CORRIGENDUM: Low-pass whole-genome sequencing in clinical cytogenetics: a validated approach
Erratum for
-
Low-pass whole-genome sequencing in clinical cytogenetics: a validated approach.Genet Med. 2016 Sep;18(9):940-8. doi: 10.1038/gim.2015.199. Epub 2016 Jan 28. Genet Med. 2016. PMID: 26820068
Similar articles
-
Low-pass whole-genome sequencing in clinical cytogenetics: a validated approach.Genet Med. 2016 Sep;18(9):940-8. doi: 10.1038/gim.2015.199. Epub 2016 Jan 28. Genet Med. 2016. PMID: 26820068
-
Low-pass genome sequencing: a validated method in clinical cytogenetics.Hum Genet. 2020 Nov;139(11):1403-1415. doi: 10.1007/s00439-020-02185-9. Epub 2020 May 25. Hum Genet. 2020. PMID: 32451733
-
Balanced Chromosomal Rearrangement Detection by Low-Pass Whole-Genome Sequencing.Curr Protoc Hum Genet. 2018 Jan 24;96:8.18.1-8.18.16. doi: 10.1002/cphg.51. Curr Protoc Hum Genet. 2018. PMID: 29364520 Free PMC article.
-
[The future of cytogenetics after the sequencing of the human genome].Morphologie. 2004 Apr;88(280):19-23. doi: 10.1016/s1286-0115(04)97993-3. Morphologie. 2004. PMID: 15208808 Review. French.
-
From cytogenetics to next-generation sequencing technologies: advances in the detection of genome rearrangements in tumors.Biochem Cell Biol. 2008 Apr;86(2):81-91. doi: 10.1139/O08-003. Biochem Cell Biol. 2008. PMID: 18443621 Review.
Cited by
-
High chromosome instability identified by low-pass whole-genome sequencing assay is associated with TP53 copy loss and worse prognosis in BRCA1 germline mutation breast cancer.Breast Cancer. 2022 Jan;29(1):103-113. doi: 10.1007/s12282-021-01286-1. Epub 2021 Aug 17. Breast Cancer. 2022. PMID: 34403063 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources